7601 Lactate racemase N-terminal domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 2 | 0.9 | 2.36× | not tested | |
| Homogeneous metal compounds | 3 | 1.9 | 1.55× | not tested | |
| Organic oxygen compounds | 1 | 0.8 | 1.27× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
No DrugBank compounds are annotated on this group's domains.
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NImetal | NICKEL (II) ION | 12 |
| 4EY | 3-methanethioyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium | 10 |
| ENJ | (4S)-5-methanethioyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-4-sulfo-1,4-dihydropyridine-3-carbothioic S-acid | 3 |
| CL | CHLORIDE ION | 2 |
| LAC | LACTIC ACID | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| SO3 | SULFITE ION | 2 |
| VAD | DEAMINOHYDROXYVALINE | 2 |
| UCU | (2R)-2-oxidanylbutanoic acid | 1 |